🚀 VC round data is live in beta, check it out!
P3 Health Partners Valuation Multiples
Discover revenue and EBITDA valuation multiples for P3 Health Partners and similar public comparables like Maternus-Kliniken, Biote, DocGo, Radius Residential and more.
P3 Health Partners Overview
About P3 Health Partners
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Founded
2020
HQ
Employees
360
Website
Sectors
Financials (LTM)
EV
$269M
P3 Health Partners Financials
P3 Health Partners reported last 12-month revenue of $1B and negative EBITDA of ($116M).
In the same LTM period, P3 Health Partners generated ($116M) in EBITDA losses and had net loss of ($160M).
Revenue (LTM)
P3 Health Partners P&L
In the most recent fiscal year, P3 Health Partners reported revenue of $1B and EBITDA of ($149M).
P3 Health Partners expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA | ($116M) | XXX | ($149M) | XXX | XXX | XXX |
| EBITDA Margin | (8%) | XXX | (10%) | XXX | XXX | XXX |
| EBIT Margin | (15%) | XXX | (19%) | XXX | XXX | XXX |
| Net Profit | ($160M) | XXX | ($148M) | XXX | XXX | XXX |
| Net Margin | (11%) | XXX | (10%) | XXX | XXX | XXX |
| Net Debt | — | — | $248M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
P3 Health Partners Stock Performance
P3 Health Partners has current market cap of $9M, and enterprise value of $269M.
Market Cap Evolution
P3 Health Partners' stock price is $2.64.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $269M | $9M | -4.7% | XXX | XXX | XXX | $-44.91 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialP3 Health Partners Valuation Multiples
P3 Health Partners trades at 0.2x EV/Revenue multiple, and (2.3x) EV/EBITDA.
EV / Revenue (LTM)
P3 Health Partners Financial Valuation Multiples
As of April 11, 2026, P3 Health Partners has market cap of $9M and EV of $269M.
Equity research analysts estimate P3 Health Partners' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
P3 Health Partners has a P/E ratio of (0.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $269M | XXX | $269M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | (2.3x) | XXX | (1.8x) | XXX | XXX | XXX |
| EV/EBIT | (1.2x) | XXX | (1.0x) | XXX | XXX | XXX |
| P/E | (0.1x) | XXX | (0.1x) | XXX | XXX | XXX |
| EV/FCF | (3.6x) | XXX | (2.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified P3 Health Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
P3 Health Partners Margins & Growth Rates
P3 Health Partners' revenue in the last 12 month grew by 5%.
P3 Health Partners' revenue per employee in the last FY averaged $4.1M, while opex per employee averaged $4.8M for the same period.
P3 Health Partners' rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
P3 Health Partners' rule of X is 12% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
P3 Health Partners Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | (8%) | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Growth | (88%) | XXX | (81%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 4% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 12% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $4.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $4.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 119% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
P3 Health Partners Public Comps
See public comps and valuation multiples for other Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Biote | XXX | XXX | XXX | XXX | XXX | XXX |
| DocGo | XXX | XXX | XXX | XXX | XXX | XXX |
| Radius Residential | XXX | XXX | XXX | XXX | XXX | XXX |
| Joint | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
P3 Health Partners M&A Activity
P3 Health Partners acquired XXX companies to date.
Last acquisition by P3 Health Partners was on XXXXXXXX, XXXXX. P3 Health Partners acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by P3 Health Partners
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialP3 Health Partners Investment Activity
P3 Health Partners invested in XXX companies to date.
P3 Health Partners made its latest investment on XXXXXXXX, XXXXX. P3 Health Partners invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by P3 Health Partners
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout P3 Health Partners
| When was P3 Health Partners founded? | P3 Health Partners was founded in 2020. |
| Where is P3 Health Partners headquartered? | P3 Health Partners is headquartered in United States. |
| How many employees does P3 Health Partners have? | As of today, P3 Health Partners has over 360 employees. |
| Who is the CEO of P3 Health Partners? | P3 Health Partners' CEO is Aric Coffman. |
| Is P3 Health Partners publicly listed? | Yes, P3 Health Partners is a public company listed on Nasdaq. |
| What is the stock symbol of P3 Health Partners? | P3 Health Partners trades under PIII ticker. |
| When did P3 Health Partners go public? | P3 Health Partners went public in 2021. |
| Who are competitors of P3 Health Partners? | P3 Health Partners main competitors are Maternus-Kliniken, Biote, DocGo, Radius Residential. |
| What is the current market cap of P3 Health Partners? | P3 Health Partners' current market cap is $9M. |
| What is the current revenue of P3 Health Partners? | P3 Health Partners' last 12 months revenue is $1B. |
| What is the current revenue growth of P3 Health Partners? | P3 Health Partners revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of P3 Health Partners? | Current revenue multiple of P3 Health Partners is 0.2x. |
| Is P3 Health Partners profitable? | No, P3 Health Partners is not profitable. |
| What is the current EBITDA of P3 Health Partners? | P3 Health Partners has negative EBITDA and is not profitable. |
| What is P3 Health Partners' EBITDA margin? | P3 Health Partners' last 12 months EBITDA margin is (8%). |
| What is the current EV/EBITDA multiple of P3 Health Partners? | Current EBITDA multiple of P3 Health Partners is (2.3x). |
| What is the current FCF of P3 Health Partners? | P3 Health Partners' last 12 months FCF is ($74M). |
| What is P3 Health Partners' FCF margin? | P3 Health Partners' last 12 months FCF margin is (5%). |
| What is the current EV/FCF multiple of P3 Health Partners? | Current FCF multiple of P3 Health Partners is (3.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.